UNSPSC 51373416: Brompheniramine/codeine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373416 Brompheniramine/codeine/phenylephrine is a Commodity code that frames pharmaceutical and medical products supplied to state and local health and corrections agencies. Recent solicitations show state and local governments buying parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems through this code — a scope broader than the code name alone suggests and driven by corrections health care, community health initiatives, and emergency response. The Washington State Department of Corrections issued RFQ RFQQK13020 in September 2026 seeking parenteral products, services, and equipment — including TPN and PPN solutions, IV fluids, and controlled substances — for eight correctional facilities across three regions, with response due October 7, 2026 and emphasis on small business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) participation. Issuers include state health and corrections departments and county health agencies; the Washington DOC and Seminole County, Florida both appear in recent solicitations, though the source does not indicate a clear pattern of repeat buyers across multiple states or jurisdictions.

Geographic activity spans Washington and Florida in the recent record. The Washington State Department of Corrections procurement covers facilities in West, Central, and East regions across the state with multiple-award potential (up to three contractors per region) for a contract term November 26, 2026 through June 30, 2030, fixed pricing for the initial two-year term, and strict delivery performance requirements—PN bags within 24 hours and other parenteral products within 8 hours. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, a two-year initial term with one-year renewal option, and potential FEMA funding. The source does not support a characterization of geographic concentration or activity in other states beyond these two opportunities.